A privately held company based in the United States, specializing in a portfolio of instruments for single-cell dispensing and imaging. Their products serve the clinical, biopharmaceutical, and food & beverage industries, aiming to improve precision, efficiency, and quality in scientific research, diagnostics, and manufacturing applications across various sectors.
The client sought to expand their presence in Europe by building a robust sales pipeline and supporting their BD team. With a portfolio of instruments for single-cell dispensing and imaging, the company needed to engage pharmaceutical and biotech companies in biotherapeutic and cell & gene therapy sectors.
Novoptim identified the need to implement a systematic inside sales process to manage lead generation and nurture prospects efficiently. Automation tools were essential to streamline outreach efforts, and a clear segmentation strategy was developed to target key decision-makers in the pharma and biotech industries across Europe.
The inside sales process was successfully established, leveraging automation tools to generate a pipeline of $5.7 million in BANT-qualified opportunities within 10 months. Multichannel outreach efforts boosted brand awareness across Europe, positioning the company for future growth and expanding its footprint in the biotherapeutic and cell & gene therapy sectors.
Whether you’re entering the market or scaling your presence, we’re here to turn your innovation into commercial success.
